Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Petros Patos"'
Autor:
Valentin Garcia-Gutierrez, Fei Huang, Ajibade Ashaye, Mehul Dalal, Victor Laliman-Khara, Massimo Breccia, Megan Rutherford, Hoora Moradian, Petros Patos, Elias Joseph Jabbour
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundPonatinib and asciminib are approved for third-line therapy in chronic-phase chronic myeloid leukemia (CP-CML) and are the only drugs approved for patients with the T315I mutation in the United States. In Europe, only ponatinib is approved
Externí odkaz:
https://doaj.org/article/ed2b0ee3852f4e13af5b8674b7755ddf
Autor:
Josep-Maria Ribera, Thibaud Prawitz, Andreas Freitag, Anuj Sharma, Balázs Dobi, Federica Rizzo, Lorenzo Sabatelli, Petros Patos
Publikováno v:
Advances in Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c17bffeb3ea1ab71892ce62150dc9583
https://doi.org/10.1007/s12325-023-02497-y
https://doi.org/10.1007/s12325-023-02497-y